Udh Mspv
Startup rounds since 2014 with a Udh Mspv investor on the board, and the firm's own fund filings.
Raises
11
since 2014
Unannounced
1
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name
Rounds
- Human Biotech, Inc.$10M
- Alloy Therapeutics, Inc.$30M
- Angiex, Inc.$22M
- Wheeler Bio, Inc.$23.1M
- Aakha Biologics, Inc.$750K
- Mytide Therapeutics, Inc.$1.16M
- Wheeler Bio, Inc.$23.2M
- Mytide Therapeutics, Inc.$7.07M
- Wheeler Bio, Inc.$13.6M
- Vernal Biosciences, Inc.$1.5M
- Avitide, Inc.$3.44M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 2 | 1 |
| 2025 | 2 | 0 |
| 2024 | 1 | — |
| 2023 | 1 | — |
| 2022 | 2 | — |
| 2021 | 2 | — |
| 2014 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Udh Mspv II LLC | 13 Sep 2018 | Open-ended | $25K |
| Udh Mspv I LLC | 26 Oct 2017 | Open-ended | $200K |
Listed because a Udh Mspv fund's filing names a director of each company. A name match is not a verified identity.